Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study.

MLA

Ide, Tatsuya, et al. “Direct-Acting Antiviral Agents Do Not Increase the Incidence of Hepatocellular Carcinoma Development: A Prospective, Multicenter Study.” Hepatology International, vol. 13, no. 3, May 2019, pp. 293–301. EBSCOhost, https://doi.org/10.1007/s12072-019-09939-2.

APA

Ide, T., Koga, H., Nakano, M., Hashimoto, S., Yatsuhashi, H., Higuchi, N., Nakamuta, M., Oeda, S., Eguchi, Y., Shakado, S., Sakisaka, S., Yoshimaru, Y., Sasaki, Y., Honma, Y., Harada, M., Seike, M., Maeshiro, T., Miuma, S., Nakao, K., … Torimura, T. (2019). Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study. Hepatology International, 13(3), 293–301. https://doi.org/10.1007/s12072-019-09939-2

Chicago

Ide, Tatsuya, Hironori Koga, Masahito Nakano, Satoru Hashimoto, Hiroshi Yatsuhashi, Nobito Higuchi, Makoto Nakamuta, et al. 2019. “Direct-Acting Antiviral Agents Do Not Increase the Incidence of Hepatocellular Carcinoma Development: A Prospective, Multicenter Study.” Hepatology International 13 (3): 293–301. doi:10.1007/s12072-019-09939-2.